Amphivena Therapeutics appoints president and CEO

Amphivena Therapeutics Inc, a private clinical stage immuno-oncology company, has named Dr. Curtis L. Ruegg as president and CEO.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this